86 related articles for article (PubMed ID: 7902207)
1. Regulation of activity levels of glycolipid sulfotransferases by transforming growth factor alpha in renal cell carcinoma cells.
Kobayashi T; Honke K; Gasa S; Imai S; Tanaka J; Miyazaki T; Makita A
Cancer Res; 1993 Dec; 53(23):5638-42. PubMed ID: 7902207
[TBL] [Abstract][Full Text] [Related]
2. [Sulfolipids and glycolipid sulfotransferases in a human renal cell carcinoma cell line].
Kobayashi T
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):522-30. PubMed ID: 1427596
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated expression of glycolipid sulfotransferase gene in human renal cell carcinoma cells.
Honke K; Tsuda M; Hirahara Y; Miyao N; Tsukamoto T; Satoh M; Wada Y
Cancer Res; 1998 Sep; 58(17):3800-5. PubMed ID: 9731487
[TBL] [Abstract][Full Text] [Related]
4. Involvement of protein kinase C in the regulation of glycolipid sulfotransferase activity levels in renal cell carcinoma cells.
Kobayashi T; Honke K; Gasa S; Sugiura M; Miyazaki T; Ishizuka I; Makita A
Cancer Res; 1993 Jun; 53(11):2484-9. PubMed ID: 8098660
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor elevates the activity levels of glycolipid sulfotransferases in renal-cell-carcinoma cells.
Kobayashi T; Honke K; Gasa S; Kato N; Miyazaki T; Makita A
Int J Cancer; 1993 Sep; 55(3):448-52. PubMed ID: 8104164
[TBL] [Abstract][Full Text] [Related]
6. Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha.
Atlas I; Mendelsohn J; Baselga J; Fair WR; Masui H; Kumar R
Cancer Res; 1992 Jun; 52(12):3335-9. PubMed ID: 1596891
[TBL] [Abstract][Full Text] [Related]
7. Sulfolipids and glycolipid sulfotransferase activities in human renal cell carcinoma cells.
Kobayashi T; Honke K; Kamio K; Sakakibara N; Gasa S; Miyao N; Tsukamoto T; Ishizuka I; Miyazaki T; Makita A
Br J Cancer; 1993 Jan; 67(1):76-80. PubMed ID: 8094007
[TBL] [Abstract][Full Text] [Related]
8. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
[TBL] [Abstract][Full Text] [Related]
9. Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line.
Korc M; Chandrasekar B; Shah GN
Cancer Res; 1991 Dec; 51(23 Pt 1):6243-9. PubMed ID: 1933884
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor elevates the activity levels of glycolipid sulfotransferases in renal cell carcinoma cells.
Kobayashi T; Honke K; Gasa S; Miyazaki T; Tajima H; Matsumoto K; Nakamura T; Makita A
Eur J Biochem; 1994 Jan; 219(1-2):407-13. PubMed ID: 8307006
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma.
Walker C; Everitt J; Freed JJ; Knudson AG; Whiteley LO
Cancer Res; 1991 Jun; 51(11):2973-8. PubMed ID: 2032234
[TBL] [Abstract][Full Text] [Related]
12. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the regulation of glycolipid sulfotransferase activity in human renal cancer cells].
Yabunaka N
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):289-300. PubMed ID: 7774881
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
[TBL] [Abstract][Full Text] [Related]
15. Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings.
Sanfilippo JS; Rao CV; Guarnaschelli JJ; Woost PG; Byrd VM; Jones E; Schultz GS
Surg Gynecol Obstet; 1993 Nov; 177(5):488-96. PubMed ID: 8211601
[TBL] [Abstract][Full Text] [Related]
16. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene.
Untawale S; Zorbas MA; Hodgson CP; Coffey RJ; Gallick GE; North SM; Wildrick DM; Olive M; Blick M; Yeoman LC
Cancer Res; 1993 Apr; 53(7):1630-6. PubMed ID: 8453634
[TBL] [Abstract][Full Text] [Related]
18. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.
Hofer DR; Sherwood ER; Bromberg WD; Mendelsohn J; Lee C; Kozlowski JM
Cancer Res; 1991 Jun; 51(11):2780-5. PubMed ID: 2032218
[TBL] [Abstract][Full Text] [Related]
19. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha.
Nakamura N; Shidoji Y; Moriwaki H; Muto Y
Biochem Biophys Res Commun; 1996 Feb; 219(1):100-4. PubMed ID: 8619789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
